Chloroform → 7-{[(1-{[(2R)-3,8-Dioxo-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylen-2-yl]methyl}-4-piperidinyl)amino]methyl}-2,3-dihydro-1,4-benzodioxin-5-carbonitrile hydrochloride
反応式
[NH2:1][CH:2]1[CH2:7][CH2:6][N:5]([CH2:8][C@H:9]2[N:19]3[C:20]4[N:11]([C:12](=[O:22])[CH:13]=[CH:14][C:15]=4[N:16]=[CH:17][C:18]3=[O:21])[CH2:10]2)[CH2:4][CH2:3]1.[CH:23]([C:25]1[CH:26]=[C:27]([C:35]#[N:36])[C:28]2[O:33][CH2:32][CH2:31][O:30][C:29]=2[CH:34]=1)=O.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+].C([O-])(O)=O.[Na+].C(Cl)(Cl)[Cl:57]>CO>[ClH:57].[O:21]=[C:18]1[CH:17]=[N:16][C:15]2=[C:20]3[N:19]1[C@H:9]([CH2:8][N:5]1[CH2:6][CH2:7][CH:2]([NH:1][CH2:23][C:25]4[CH:26]=[C:27]([C:35]#[N:36])[C:28]5[O:33][CH2:32][CH2:31][O:30][C:29]=5[CH:34]=4)[CH2:3][CH2:4]1)[CH2:10][N:11]3[C:12](=[O:22])[CH:13]=[CH:14]2参加物
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
A suspension of (2R)-2-[(4-amino-1-piperidinyl)methyl]-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione (for a preparation see Example 16A(j)) (60 mg, 0.199 mmol) and 7-formyl-2,3-dihydro-1,4-benzodioxin-5-carbonitrile (for a synthesis see WO06014580 Preparation 13 or WO2007122258, Example 31(d)) (37.7 mg, 0.199 mmol) in chloroform (2 ml) and methanol (0.100 ml) at room temperature under nitrogen was treated with sodium triacetoxyborohydride (127 mg, 0.597 mmol) and stirred for 90 min. This was then treated with saturated aqueous NaHCO3(10 ml) and extracted with 20% methanol/DCM (3×25 ml). The combined organic extracts were dried (NaSO4), filtered, evaporated and purified using silica chromatography (0-20% methanol/DCM) to give the free base of the title compound as a yellow gum (40 mg, 42.3%).
後処理
- extractionextracted with 20% methanol/DCM (3×25 ml)
- dry with materialThe combined organic extracts were dried (NaSO4)
- filtrationfiltered
- customevaporated
- custompurified
出典と根拠
- ORDレコード
- ord-1570d810b1ee476780e0b5594366d4ac
- 出典データセット
- uspto-grants-2013_03
- 特許番号
- US08389524B2
反応ノート
読み込み中…